Sun Pharma board to consider up to ₹15,000 crore NCD issue
Sun Pharmaceutical Industries said its board will meet Oct. 12 to consider issuing listed, rated, unsecured and redeemable non-convertible debentures worth up to ₹15,000 crore.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.